相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
Chand Khanna et al.
CLINICAL CANCER RESEARCH (2014)
Analysis of Serum Insulin Growth Factor-1 Concentrations in Localized Osteosarcoma: A Children's Oncology Group Study
Scott C. Borinstein et al.
PEDIATRIC BLOOD & CANCER (2014)
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Sharon A. Savage et al.
NATURE GENETICS (2013)
Outcome for adolescent and young adult patients with osteosarcoma
Katherine A. Janeway et al.
CANCER (2012)
Poor Survival for Osteosarcoma of the Pelvis: A Report from the Children's Oncology Group
Michael S. Isakoff et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2012)
Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
David Ebb et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Detectable clonal mosaicism and its relationship to aging and cancer
Kevin B. Jacobs et al.
NATURE GENETICS (2012)
Investigation of the Insulin-Like Growth Factor-1 Signaling Pathway in Localized Ewing Sarcoma A Report From the Children's Oncology Group
Scott C. Borinstein et al.
CANCER (2011)
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC
L. Ren et al.
ONCOGENE (2009)
Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier
Rui Yang et al.
BMC CANCER (2008)
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
Tadahiko Kubo et al.
CANCER (2008)
Polymorphisms and methylation of the reduced folate carrier in osteosarcoma
Rui Yang et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Hypoxia markers in human osteosarcoma:: An exploratory study
Hiroo Mizobuchi et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma
Xin-Yan Lu et al.
MOLECULAR CANCER RESEARCH (2008)
Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma
Rui Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells
Yi Guo et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2007)
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Cindy L. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The folate receptor α is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate
Rui Yang et al.
CLINICAL CANCER RESEARCH (2007)
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors
A. M. Deshpande et al.
ONCOGENE (2007)
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
C Khanna et al.
NATURE MEDICINE (2004)
Determination of a minimal region of loss of heterozygosity on chromosome 18Q21.33 in osteosarcoma
TL Johnson-Pais et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials
WA Bleyer
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial
WS Ferguson et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2001)
分享论文
